VEA
HLVX

Virtus ETF Advisers’s HilleVax HLVX Stock Holding History

Virtus ETF Advisers’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,230
Closed -$11K – 484
2024
Q3 		$11K Buy
6,230
+113
+2% +$290 0.01% 453
2024
Q2 		$88.5K Buy
+6,117
New +$84K 0.04% 367

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Virtus ETF Advisers's HLVX Position: Q4 2024 in Review

Virtus ETF Advisers sold out of HilleVax (HLVX) in Q4 2024, closing a stake of 6,230 shares — an estimated $11K sold.

Virtus ETF Advisers first reported a position in HLVX in Q2 2024 and held it in 2 quarters. The position peaked at $88.5K in Q2 2024. 76 funds tracked by Wall St. Rank hold HLVX as of Q4 2024.

  • Virtus ETF Advisers reported no remaining HilleVax position as of Q4 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 6,230 HilleVax shares in Q4 2024, an estimated $11K.
  • Virtus ETF Advisers first reported a position in HilleVax in Q2 2024 and held it in 2 quarters.
  • Virtus ETF Advisers's HilleVax position peaked at $88.5K in Q2 2024.
  • 76 funds tracked by Wall St. Rank held HilleVax as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.